VANCOUVER, July 16, 2018 /CNW/ - Zecotek Photonics
Inc. ("Zecotek" or the "Company") (TSX-V: ZMS)
(Frankfurt: W1I), a developer of leading-edge photonics
technologies for healthcare, industrial and scientific
markets, is pleased to announce that the same group which made the
$5 million investment in Zecotek
Imaging China, announced in January
2018, has invested an additional $2
million to acquire another 2% interest in the Company's
wholly owned subsidiary, Zecotek Imaging Systems Pte. Ltd. The
divisional financing was based solely on the appraised
pre-commercialized value of approximately $100 million.
"With recent M&A activity in the photo detector
manufacturing marketplace, we have observed a significant increase
of interest in our patented high dynamic range
photo-detectors," said Dr. A.F. Zerrouk, Chairman,
President, and CEO of Zecotek Photonics Inc. "The funds raised
in this divisional equity financing will be used to initiate the
manufacturing of the new generation series of solid-state
micro-pixel avalanche photo diodes and transistors (MAPD/T) by our
associates at the Malaysian Institute of Microelectronics Systems.
We are moving to full production and commercialization to meet the
increasing demand for medical imaging, high energy physics and
other industrial applications, such as LIDAR and autonomous cars,
and leverage the significant performance advantages of our
MAPD/T."
Zecotek's patented MAPD/T offers significant performance-cost
advantages over competing photomultiplier tubes (PMT) and other
solid-state, silicon based photo detectors known as SiPM. The new
generation MAPD/T have low manufacturing cost, excellent timing
resolution and photon detection efficiency - key characteristics
for the new configurations of high resolution PET medical scanners.
Solid-state MAPD/T also offer superior recovery time, unique
radiation hardness and display of the highest possible linearity
making them prime components for the improved detector designs
required in high energy experiments at the Chinese Institute of
High Energy Physics (IHEP) and CERN. Zecotek's pioneering MAPD
technology can also be used to manufacture two-dimensional arrays
of solid-state photo detectors, which allows for the manufacture
and implementation of both very large-area detectors and compact
position-sensitive arrays.
About Malaysian Institute of Microelectronic Systems
(MIMOS):
MIMOS is Malaysia's premier
Applied Research and Development Centre in Information and
Communications Technology, Industrial Electronics Technology and
Nano-Semiconductor Technology. As a strategic agency under the
Ministry of Science, Technology and Innovation (MOSTI), MIMOS
contributes to raising Malaysia's
competitiveness by pioneering market creation for Malaysian
technopreneurs through patentable technology platforms, products
and solutions. Over the past 12 years, MIMOS has filed more than
2,000 Intellectual Properties in various technology domains and
across key socio-economic areas. Serving a central role in
Malaysia's transformation journey
and ICT Vision, MIMOS endeavors to create a culture of innovation
by nurturing relationships with internal and external stakeholders,
in the spirit of smart partnerships and inclusive growth models and
strategies. For more information visit: http://www.mimos.my.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS) (Frankfurt: W1I) (OTCPK:
ZMSPF) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, 3D metal printing, and lasers for applications in
medical, high-tech and industrial sectors. Founded in 2004, Zecotek
operates three divisions: Imaging Systems, Optronics Systems and 3D
Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances with Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Shanghai
EBO Optoelectronics Technology Co. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit http://www.zecotek.com and follow @zecotek on
Twitter.
This press release may contain forward-looking statements
that are based on management's expectations,
estimates, projections and assumptions. These statements are not
guarantees of future performance and involve certain risks and
uncertainties, which are difficult to predict. Therefore, actual
future results and trends may differ materially from what may have
been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at http://www.zecotek.com.
SOURCE Zecotek Photonics Inc